In BC cells treated with SMYD3 shRNA/control shRNA, we found that SMYD3 exerted its anti-apoptotic effect by up-regulating the expression of Bcl-2 and down-regulating the expression of Bax and Bad (Figure 3C). Here, SMYD3 is linked to breast cancer.